📰 Small Pharma News
Small Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Small Pharma. Real-time updates on events, politics, business and more.
May 2, 2024
/PRNewswire/ -- Allucent, a global mid-sized clinical research organization (CRO), received two CRO Leadership Awards presented by Clinical Leader and Life...
April 11, 2024
Small Pharma Inc. (CVE:DMT – Get Free Report)’s share price fell 6.3% on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. 1,890,765 shares traded hands during trading, an increase of 538% from the average session volume of 296,159 shares. The stock had previously closed at C$0.16. Small Pharma Trading […]
December 31, 2023
In February, India appointed Raghuvanshi, the first DCGI from the corporate world who boasted of stints at Ranbaxy and Dr. Reddy’s among others
October 30, 2023
Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted Psychedelics companies Cybin Inc. (NYSE:CYBN) and Small Pharma I...
October 30, 2023
Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted
October 27, 2023
Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.
October 25, 2023
TSX VENTURE COMPANIES Minto Metals Corp. BULLETIN TYPE: Delist BULLETIN DATE: 24, 2023 TSX Venture Tier 2 Company Further to TSX Venture Exchange bulletin dated 07, 2023, effective at the close of business on Tuesday, 31, 2023, the common shares... - Veroeffentlicht am 25.10.2023
October 24, 2023
TORONTO & LONDON, October 23, 2023--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) ("Cybin", or the "Company") and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) ("Small Pharma") are pleased to announce the completion of the previously-announced acquisition by Cybin of Small Pharma by way of a plan of arrangement under the Business Corporations Act (British Columbia), and pursuant to the terms of an arrangement agreement dated August 28, 2023 between Cybin and Small Ph...
October 23, 2023
This news release constitutes a “designated news release” for the purposes of Cybin’s prospectus supplements each dated August 23, 2023, to its short form base shelf prospectus dated August 17,...
October 23, 2023
Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCQB: DMTTF) have completed their August acquisition agreement.